Find similar content

Source channel @githubtrending · Post #14866 · Jun 25

#typescript#admin#admin_template#elegant#naive_ui#naive_ui_admin#pinia#typescript#unocss#vite6#vue#vue_admin#vue3 SoybeanAdmin is a modern, elegant, and powerful backend management template built with the latest technologies like Vue3, Vite6, TypeScript, Pinia, and UnoCSS. It offers a clear project structure, strict code standards, automated file routing, and built-in internationalization. It supports flexible permission routing, rich page components, and mobile-friendly layouts, making it ready to use without extra setup. This helps you quickly build or learn advanced admin systems with high code quality and customization options, saving time and improving development efficiency. It also provides command-line tools and mock data support for easier development and testing[1][4][5]. https://github.com/soybeanjs/soybean-admin

Hashtags

#typescript #admin #admin_template #elegant #naive_ui #naive_ui_admin #pinia #unocss #vite6 #vue #vue_admin #vue3

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment